0001209191-20-047504.txt : 20200819 0001209191-20-047504.hdr.sgml : 20200819 20200819163546 ACCESSION NUMBER: 0001209191-20-047504 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200817 FILED AS OF DATE: 20200819 DATE AS OF CHANGE: 20200819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olson Eric R CENTRAL INDEX KEY: 0001678149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 201117459 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-17 0 0001556263 Syros Pharmaceuticals, Inc. SYRS 0001678149 Olson Eric R C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 0 1 0 0 Chief Scientific Officer Common Stock 2020-08-17 4 M 0 4963 1.01 A 4963 D Common Stock 2020-08-17 4 S 0 4963 13.00 D 0 D Common Stock 2020-08-18 4 M 0 10787 1.01 A 10787 D Common Stock 2020-08-18 4 S 0 10787 13.00 D 0 D Stock Option (right to buy) 1.01 2020-08-17 4 M 0 4963 0.00 D 2023-05-22 Common Stock 4963 105112 D Stock Option (right to buy) 1.01 2020-08-18 4 M 0 10787 0.00 D 2023-05-22 Common Stock 10787 94325 D The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This option is fully vested. /s/ Gerald E. Quirk, as attorney-in-fact 2020-08-19